Abstract
As more radiopharmaceuticals garner regulatory approval and are subsequently reimbursed, more facilities for the production of radiopharmaceuticals will be needed. Setting up a successful radiopharmaceutical production facility can be a daunting task, but careful consideration during the planning stages can help ensure an efficient operation. In this regard, important questions include whether the facility will focus solely on research agents, if the production of commercial radiopharmaceuticals will take place, and whether agents for targeted radiotherapy will be produced. Properly trained staff and a detailed quality assurance system are also keys to success.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Archives and Records Administration. Office of the Federal Register. Electronic Code of Federal Regulations. Current good manufacturing practice for positron emission tomography drugs. Sect. Part 212. https://catalog.data.gov/dataset/electronic-code-of-federal-regulations.
United States Pharmacopeia. Positron emission tomography drugs for compounding, investigational, and research uses. Sect. Chapter 823. USP40-NF35.
National Archives and Records Administration. Office of the Federal Register. Electronic Code of Federal Regulations. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; General. Sect. Part 210. https://catalog.data.gov/dataset/electronic-code-of-federal-regulations.
U.S. Food and Drug Administration. FDA guidance for Industry: Process validation: general principles and practices. 2011.
National Archives and Records Administration. Office of the Federal Register. Electronic Code of Federal Regulations. Quality system regulation. Sect. Part 820.
United States Pharmacopeia. Positron emission tomography drugs-information. Sect. Chapter 1823. USP40–NF35.
U.S. Food and Drug Administration. FDA guidance for industry: Sterile drug products produced by aseptic processing – current good manufacturing practice. 2004.
U.S. Food and Drug Administration. Q3C – Tables and list guidance for industry. 2017.
United States Pharmacopeia. USP Monographs: Fludeoxyglucose F 18 Injection. Sect. USP40-NF35 p. 4520.
United States Pharmacopeia. Bacterial endotoxins test. Sect. Chapter 85. USP40-NF35.
Milton MJT, Wielgosz RI. Uncertainty in SI-traceable measurements of amount of substance by isotope dilution mass spectrometry. Metrologia. 2000;37(3):199.
Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. J Nucl Med. 2010;51(8):1293–300.
Anderson CJ, Schwarz SW, Connett JM, Cutler PD, Guo LW, Germain CJ, et al. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab′)2. J Nucl Med. 1995;36(5):850–8.
Paul-Dauphin S, Karaca F, Morgan TJ, Millan-Agorio M, Herod AA, Kandiyoti R. Probing size exclusion mechanisms of complex hydrocarbon mixtures: the effect of altering eluent compositions. Energy Fuel. 2007;21(6):3484–9.
U.S. Food and Drug Administration. Center for Drug Evaluation and Research (CDER). FDA guidance for industry: Media fills for validation of aseptic preparations for positron emission tomography (pet) drugs. 2012.
USP General Chapter ⟨1823⟩ Positron Emission Tomography Drugs – Information. United States Pharmacopeial Convention; 2017.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mishoe, A., DeNoble, P. (2019). Setting Up a Successful Radiopharmaceutical Production Facility. In: Lewis, J., Windhorst, A., Zeglis, B. (eds) Radiopharmaceutical Chemistry. Springer, Cham. https://doi.org/10.1007/978-3-319-98947-1_37
Download citation
DOI: https://doi.org/10.1007/978-3-319-98947-1_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98946-4
Online ISBN: 978-3-319-98947-1
eBook Packages: MedicineMedicine (R0)